L 12 LYS 2 1.789 1.354 <=B
L 13 THR 5 2.002 1.197 <=B
L 14 PRO 10 2.316 0.900 <=B
L 15 GLU 0 2.572 2.276 <=B
L 16 GLU 0 2.748 2.432 <=B
L 17 PRO 0 2.829 2.503 <=B
L 18 LYS 2 0.823 0.499 <=B
L 19 GLU 11 -0.801 -1.974 <=B
L 20 GLU 3 -1.599 -1.760 <=B
L 21 VAL 21 -4.067 -6.014
L 22 THR 5 -6.273 -6.127
L 23 ILE 28 -8.368 -10.626
L 24 LYS 3 -9.814 -9.030
L 25 VAL 28 -11.027 -12.979
L 26 ASN 16 -10.489 -11.123
L 27 LEU 21 -11.188 -12.316
L 28 ILE 12 -9.548 -9.830
L 29 PHE 16 -9.289 -10.060
L 30 ALA 13 -7.090 -7.769
L 31 ASP 8 -5.649 -5.920
L 32 GLY 1 -5.935 -5.368
L 33 LYS 8 -6.493 -6.666
L 34 ILE 6 -8.071 -7.833
L 35 GLN 15 -9.100 -9.778
L 36 THR 4 -9.664 -9.012
L 37 ALA 25 -10.509 -12.176
L 38 GLU 5 -9.849 -9.291
L 39 PHE 24 -8.371 -10.169
L 40 LYS 1 -6.002 -5.427
L 41 GLY 13 -4.190 -5.203
L 42 THR 10 -3.292 -4.064
L 43 PHE 10 -4.697 -5.307
L 44 GLU 4 -5.092 -4.967
L 45 GLU 13 -5.395 -6.270
L 46 ALA 21 -7.570 -9.115
L 47 THR 13 -9.068 -9.520
L 48 ALA 5 -8.672 -8.249
L 49 GLU 22 -9.563 -10.993
L 50 ALA 34 -11.234 -13.852
L 51 TYR 9 -11.187 -10.936
L 52 ARG 9 -10.248 -10.104
L 53 TYR 24 -11.277 -12.740
L 54 ALA 28 -11.946 -13.792
L 55 ASP 5 -10.679 -10.026
L 56 LEU 8 -10.486 -10.200
L 57 LEU 27 -10.586 -12.474
L 58 ALA 15 -9.801 -10.398
L 59 LYS 6 -7.815 -7.606
L 60 VAL 5 -6.750 -6.549
L 61 ASN 21 -8.918 -10.308
L 62 GLY 16 -8.793 -9.622
L 63 GLU 1 -8.966 -8.050
L 64 TRP 26 -10.135 -11.960
L 65 THR 3 -9.760 -8.983
L 66 ALA 26 -10.686 -12.447
L 67 ASP 7 -9.512 -9.223
L 68 LEU 11 -9.217 -9.422
L 69 GLU 9 -7.753 -7.897
L 70 ASP 12 -5.418 -6.175
L 71 GLY 7 -4.735 -4.995
L 72 GLY 13 -8.351 -8.885
L 73 ASN 8 -7.774 -7.800
L 74 CYS 3 -9.938 -9.140
L 75 MET 31 -10.747 -13.076
L 76 ASN 6 -10.468 -9.954
L 77 ILE 32 -11.433 -13.799
L 78 LYS 7 -9.996 -9.651
L 79 PHE 27 -10.037 -11.988
L 80 ALA 8 -8.215 -8.191
L 81 GLY 8 -7.185 -7.278
L 82 LYS 3 -4.708 -4.511

Identified 9 B-Cell epitope residues out of 71 total residues